D. Caños

发表

Improving the Safety and Effectiveness of Medical Device Therapy in Women.

D. Strauss, R. Zusterzeel, D. Marinac-Dabic, 2016, Journal of women's health.

Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.

David G. Strauss, William E. Sanders, I. Piña, 2014, JAMA internal medicine.

Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.

I. Piña, D. Strauss, R. Zusterzeel, 2014, Journal of the American College of Cardiology.

Disproportionality analysis for signal detection of implantable cardioverter–defibrillator‐related adverse events in the Food and Drug Administration Medical Device Reporting System

Danica Marinac-Dabic, D. Marinac-Dabic, Ellen Pinnow, 2012, Pharmacoepidemiology and drug safety.

Stroke Complicating Percutaneous Coronary Interventions: Incidence, Predictors, and Prognostic Implications

N. Weissman, G. Mintz, K. Kent, 2002, Circulation.

Troponin-I elevation in patients with increased left ventricular mass.

N. Weissman, S. Goldstein, J. Lindsay, 2003, The American journal of cardiology.

Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium

Jonathan H Seltzer, D. Cutlip, P. Vranckx, 2017, American heart journal.

Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis: Original WRIST

K. Kent, A. Pichard, L. Satler, 2001 .

Intracoronary radiation therapy using a novel beta emitter for in-stent restenosis Tungsten WRIST.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Comparative Effectiveness of Cardiac Resynchronization Therapy Defibrillators Versus Standard Implantable Defibrillators in Medicare Patients.

D. Strauss, R. Zusterzeel, D. Marinac-Dabic, 2015, The American journal of cardiology.

Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis.

N. Weissman, G. Mintz, K. Kent, 2005, The American journal of cardiology.

Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.

A. Pichard, L. Satler, R. Wolfram, 2004, The American journal of cardiology.

Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study.

M. Leinonen, P. Saikku, S. Epstein, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C.

R. Waksman, G. Ruotolo, M. Nandalur, 2007, Cardiovascular revascularization medicine : including molecular interventions.

Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of ∼ 145,000 patients.

I. Piña, D. Strauss, T. MaCurdy, 2012, JACC. Heart failure.

Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: A Review of the Literature

D. Strauss, R. Zusterzeel, Changfu Wu, 2017, Cardiology in review.

Usefulness of preprocedural coronary lesion morphology as assessed by intravascular ultrasound in predicting Thrombolysis In Myocardial Infarction frame count after percutaneous coronary intervention in patients with Q-wave acute myocardial infarction.

N. Weissman, G. Mintz, A. Pichard, 2003, The American journal of cardiology.

Acute procedural complications and in-hospital events after percutaneous coronary interventions: eptifibatide versus abciximab.

K. Kent, A. Pichard, L. Satler, 2003, Cardiovascular radiation medicine.

Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.

A. Pichard, J. Lindsay, G. Aggrey, 2004, The American journal of cardiology.

Usefulness of gamma intracoronary radiation for totally occluded in-stent restenotic coronary narrowing.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

The initial course of in-stent restenosis influences the response to vascular brachytherapy.

A. Pichard, L. Satler, R. Wolfram, 2002, Cardiovascular radiation medicine.

Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Original WRIST. Washington Radiation for In-Stent Restenosis Trial.

K. Kent, A. Pichard, L. Satler, 2001, Cardiovascular radiation medicine.

Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials.

D. Strauss, R. Zusterzeel, Changfu Wu, 2018, Journal of women's health.

Impact of the acute results on the long‐term outcome after the treatment of in‐stent restenosis: A serial intravascular ultrasound study

N. Weissman, G. Mintz, R. Waksman, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association of Serum Antibodies to Heat-Shock Protein 65 With Coronary Calcification Levels: Suggestion of Pathogen-Triggered Autoimmunity in Early Atherosclerosis

A. Quyyumi, S. Epstein, G. Csako, 2004, Circulation.

Decision Memo for Magnetic Resonance Imaging (MRI) (CAG-00399R4)

D. Caños, Joseph D. Hutter, D. Canos, 2018 .

Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2004, The American journal of cardiology.

Vascular complications following coronary intervention correlate with long‐term cardiac events

K. Kent, A. Pichard, L. Satler, 2004, Catheterization and cardiovascular interventions.

Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

Cardiac Resynchronization Therapy De ﬁ brillators Versus Standard Implantable De ﬁ brillators in Medicare Patients

D. Strauss, R. Zusterzeel, D. Marinac-Dabic, 2015 .

Comparison of intracoronary gamma radiation for in-stent restenosis in saphenous vein grafts versus native coronary arteries.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

Serial intravascular ultrasound comparison of the extent and distribution of intimal hyperplasia six months after stent implantation for de novo versus in-stent restenosis lesions.

N. Weissman, G. Mintz, K. Kent, 2005, The American journal of cardiology.

Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, The American journal of cardiology.

Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, American Journal of Cardiology.

Three‐year follow‐up after intravascular γ‐radiation for in‐stent restenosis in saphenous vein grafts

P. Teirstein, K. Kent, A. Pichard, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft.

K. Kent, A. Pichard, L. Satler, 2003, American heart journal.

The potential role of resistin in atherogenesis.

M. Burnett, S. Epstein, T. Kinnaird, 2005, Atherosclerosis.

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

N. Weissman, G. Mintz, K. Kent, 2003, The American journal of cardiology.

Diagnosis of cardiogenic shock without the use of a pulmonary artery catheter

F. Asch, J. Panza, H. Cooper, 2015, European heart journal. Acute cardiovascular care.

Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank.

D. Mark, H. Calkins, P. Kowey, 2010, American heart journal.

Choline/betaine habitual intake and incident coronary heart disease

D. Caños, D. Canos, 2013 .

Toward Sex-Specific Guidelines for Cardiac Resynchronization Therapy?

D. Strauss, R. Zusterzeel, F. Prinzen, 2016, Journal of Cardiovascular Translational Research.

Brachytherapy and bivalirudin evaluation study.

K. Kent, A. Pichard, L. Satler, 2005, American heart journal.

The proximal location of stenosis in the left anterior descending coronary artery is not a predictive factor of worse outcome in the era of the stent.

A. Pichard, L. Satler, R. Wolfram, 2002, Cardiovascular radiation medicine.

Predictors of Subacute Stent Thrombosis: Results of a Systematic Intravascular Ultrasound Study

N. Weissman, G. Mintz, A. Pichard, 2003, Circulation.

Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

I. Piña, D. Strauss, R. Zusterzeel, 2015, Journal of women's health.

Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, Cardiovascular revascularization medicine : including molecular interventions.

Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort.

H. Calkins, D. Strauss, R. Zusterzeel, 2018, JACC. Clinical electrophysiology.

Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.

S. Solomon, R. Califf, C. O'connor, 2018, Journal of the American College of Cardiology.

Cardiac Resynchronization Therapy in Women Versus Men: Observational Comparative Effectiveness Study From the National Cardiovascular Data Registry

I. Piña, D. Strauss, R. Zusterzeel, 2015, Circulation. Cardiovascular quality and outcomes.

Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound.

Akiko Maehara, Gary S Mintz, John R Laird, 2002, Journal of the American College of Cardiology.

Evaluation of cardiovascular implantable electronic device leads post implant: ElectroPhysiology Predictable And SuStainable Implementation Of National Registries (EP PASSION)

Lina Wang, Emily P. Zeitler, J. Major, 2022, Journal of Interventional Cardiac Electrophysiology.

Clinical, angiographic, and intravascular ultrasound characteristics of early saphenous vein graft failure.

N. Weissman, G. Mintz, A. Pichard, 2004, Journal of the American College of Cardiology.

The importance of gender on coronary artery size: In‐vivo assessment by intravascular ultrasound

N. Weissman, G. Mintz, A. Maehara, 2004, Clinical cardiology.

Serial volumetric intravascular ultrasound assessment of native coronary artery versus saphenous vein grafts in-stent restenosis lesions after conventional catheter-based treatment.

N. Weissman, G. Mintz, K. Kent, 2003, The American journal of cardiology.

Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patients.

N. Weissman, K. Kent, A. Pichard, 2004, The Journal of invasive cardiology.

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.

N. Weissman, K. Kent, A. Pichard, 2004, Journal of the American College of Cardiology.

Impact of intravascular ultrasound-guided direct stenting on clinical outcome of patients treated for native coronary disease.

N. Weissman, K. Kent, A. Pichard, 2004, Cardiovascular radiation medicine.

Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.